Skip to main content
Caplight Logo









iSD Immunotech

iSD Immunotech

Private
CopenhagenHealthcare & Life Scienceshttps://isdimmunotech.com

Last Round

Seed

Oct 11, 2021

Company Overview

iSD Immunotech is a biotechnology company developing peptide therapeutics to treat severe autoimmune diseases, specifically systemic lupus erythematosus (SLE) by targeting the STING pathway.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

peptide therapeuticssystemic lupus erythematosusSLESTING pathwaylupus treatmentautoimmune diseaseimmunotherapybiotech startuppreclinical developmentdrug discoverybiopharmainflammatory diseasedrug pipelinebiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iSD Immunotech Comparables

Compare iSD Immunotech with similar companies based on industry and business-model similarity.

iSD Immunotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmuneSensor Therapeutics
76%
Novartis
73%
Astellas Pharma Inc.
72%

iSD Immunotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 11, 2021
SeedNov 23, 2020

iSD Immunotech Investors

Notable investors and investment history

iSD Immunotech investors
InvestorRounds
Eir VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 11, 2021

    Raised Seed round with Eir Ventures and novoholdings.

  • Nov 23, 2020

    Completed a Seed funding round with Novo Holdings.

iSD Immunotech Filings

Explore SEC and related filing metadata, where available.

iSD Immunotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about iSD Immunotech's valuation, stock price, and market status.

Is iSD Immunotech a public or private company?

iSD Immunotech is a private company.

What is the current stock price of iSD Immunotech?

iSD Immunotech is a private company with no public stock price. No recent secondary market data is available.

How much is iSD Immunotech worth (valuation)?

Valuation information for iSD Immunotech is not publicly available.

Can I buy iSD Immunotech stock?

iSD Immunotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was iSD Immunotech's last funding round?

iSD Immunotech's most recent funding round was Seed on October 11, 2021.

Who are the main investors in iSD Immunotech?

Key investors in iSD Immunotech include Eir Ventures.

Will iSD Immunotech IPO soon?

No public IPO plans have been announced for iSD Immunotech.

How can I track iSD Immunotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iSD Immunotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Year Founded2007
Last FundingOct 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?